(Q54188782)

26 May 2018

title

Targeted mutation analysis of endometrial clear cell carcinoma. (English)

1 reference

26 May 2018

author

Martin Köbel

8

1 reference

26 May 2018

author name string

Lien N Hoang

1

1 reference

26 May 2018

Melissa K McConechy

2

1 reference

26 May 2018

Bo Meng

3

1 reference

26 May 2018

John B McIntyre

4

1 reference

26 May 2018

Carol Ewanowich

5

1 reference

26 May 2018

Cyril Blake Gilks

6

1 reference

26 May 2018

David G Huntsman

7

1 reference

26 May 2018

Cheng-Han Lee

9

1 reference

26 May 2018

publication date

13 January 2015

1 reference

26 May 2018

published in

Histopathology

1 reference

26 May 2018

volume

66

1 reference

26 May 2018

issue

5

1 reference

26 May 2018

page(s)

664-674

1 reference

26 May 2018

Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review

cites work

1 reference

Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma

21 January 2018

1 reference

Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases

21 January 2018

1 reference

Napsin A as a marker of clear cell ovarian carcinoma

21 January 2018

1 reference

The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium

21 January 2018

1 reference

Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment

21 January 2018

1 reference

Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium

21 January 2018

1 reference

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

21 January 2018

1 reference

PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.

21 January 2018

1 reference

PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.

21 January 2018

1 reference

Histotype-genotype correlation in 36 high-grade endometrial carcinomas.

21 January 2018

1 reference

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

21 January 2018

1 reference

The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.

21 January 2018

1 reference

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.

21 January 2018

1 reference

Integrated genomic characterization of endometrial carcinoma

21 January 2018

1 reference

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.

21 January 2018

1 reference

Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes

21 January 2018

1 reference

Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas

21 January 2018

1 reference

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

21 January 2018

1 reference

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

ARID1A mutations in endometriosis-associated ovarian carcinomas

21 January 2018

1 reference

Molecular characterization of uterine clear cell carcinoma

21 January 2018

1 reference

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12581

1 reference

26 May 2018

PubMed ID

25308272

1 reference

26 May 2018